Overview
A septate uterus is a congenital uterine anomaly in which a fibrous or muscular wall (septum) partially or completely divides the uterine cavity into two sections. It is classified as a Müllerian duct anomaly and results from incomplete resorption of the medial septum during embryonic development, when the two Müllerian (paramesonephric) ducts fuse to form the uterus. The external contour of the uterus typically appears normal, which distinguishes it from a bicornuate uterus. A septate uterus is considered the most common congenital uterine malformation. Many individuals with a septate uterus are asymptomatic and may remain undiagnosed until they experience reproductive difficulties. Key clinical features include recurrent pregnancy loss (particularly in the first and second trimesters), preterm delivery, malpresentation of the fetus, and infertility. The septum has a relatively poor blood supply compared to normal endometrium, which may impair embryo implantation and placental development, contributing to adverse pregnancy outcomes. Some patients may also experience dysmenorrhea (painful menstruation) or abnormal uterine bleeding. Diagnosis is typically made through imaging studies such as three-dimensional transvaginal ultrasound, magnetic resonance imaging (MRI), or saline infusion sonohysterography. Hysteroscopy combined with laparoscopy has historically been used for definitive diagnosis. The primary treatment for symptomatic patients or those with a history of reproductive failure is hysteroscopic metroplasty (surgical resection of the septum), which is a minimally invasive procedure that has been associated with improved pregnancy outcomes in many studies. However, recent evidence has prompted debate regarding the benefit of septum resection in women without prior pregnancy loss, and clinical guidelines continue to evolve on this topic.
Multifactorial
Caused by a mix of several genes and environmental factors
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
4 eventsWeill Medical College of Cornell University — NA
University Hospital, Ghent — NA
University Hospital, Ghent — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Septate uterus.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Septate uterus at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Septate uterus.
Community
No community posts yet. Be the first to share your experience with Septate uterus.
Start the conversation →Latest news about Septate uterus
Disease timeline:
New recruiting trial: Surgical Approach to Uterine Septum
A new clinical trial is recruiting patients for Septate uterus
New recruiting trial: Added Value of Three-dimensional Transvaginal Ultrasound (3D TVUS) and Gel Infusion Sonography (3D GIS) Compared With Magnetic Resonance Imaging (MRI) in the Diagnosis of Patients With Suspicion of a Uterine Septum.
A new clinical trial is recruiting patients for Septate uterus
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Septate uterus
What is Septate uterus?
A septate uterus is a congenital uterine anomaly in which a fibrous or muscular wall (septum) partially or completely divides the uterine cavity into two sections. It is classified as a Müllerian duct anomaly and results from incomplete resorption of the medial septum during embryonic development, when the two Müllerian (paramesonephric) ducts fuse to form the uterus. The external contour of the uterus typically appears normal, which distinguishes it from a bicornuate uterus. A septate uterus is considered the most common congenital uterine malformation. Many individuals with a septate uterus
How is Septate uterus inherited?
Septate uterus follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Septate uterus typically begin?
Typical onset of Septate uterus is adult. Age of onset can vary across affected individuals.
Which specialists treat Septate uterus?
4 specialists and care centers treating Septate uterus are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.